PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home »

Psychiatric Times. Vol. 23 No. 4
Pages: 1  2  3  4  
Previous
 

Breast Cancer: What Psychiatrists Need to Know

By Michelle Riba, MD, MS | April 1, 2006

Cancer treatment demands much of patients. It is important for them to exercise and modify certain behaviors, by staying slim, quitting smoking, minimizing alcohol(Drug information on alcohol) intake, and decreasing stress. They must adhere to difficult treatment regimens, endure pain (especially when there are bone metastases), tolerate changes in their work and home lives, undergo modifications in their sexual relationships, and manage anger from partners and children whose needs are not met. The role of the psychiatrist is to diagnose and treat psychiatric symptoms and disorders and provide appropriate psychotherapy, which might include support, cognitive-behavioral therapy, interpersonal therapy, couples and family work, and group therapy. Coordination of care may also be crucial, especially at times of transition, such as the transition from active treatment to palliative or hospice care.

Psychiatric interventions

Psychotherapy can, of course, be provided at various stages of the illness. With any patient, making an accurate diagnosis is essential. Within that framework, the psychiatrist can then help the patient with the treatment and medical issues. Some therapies focus on enhancing morale, and others help the patient search for meaning29 or dignity at the end of life.30 Therapy can be supportive or focused on cognitive-behavioral techniques to reduce intrusive thoughts and behavior, such as checking and feeling for cancer recurrence.

Not all patients request or accept counseling, and pushing for acceptance might not be in the patient's best interest. Psychoeducational groups, group psychotherapy, and support groups have all proved helpful for some patients. Whether such groups help patients live longer is unclear. The data to date have been inconclusive or not yet replicated.31,32 Having a meeting with husbands or significant others and children can also be quite useful to the patient, as well as to family members.

The selective serotonin reuptake inhibitors are the first antidepressants prescribed since they have few side effects and few drug interactions. Mirtazapine(Drug information on mirtazapine) (Remeron) tends to cause weight gain, and women who are already gaining weight because of corticosteroid therapy or chemotherapy may be unwilling to take it. Mirtazapine is a good agent for cachectic patients who have lost weight and need help with sleep. Venlafaxine (Effexor) and paroxetine(Drug information on paroxetine) (Paxil) have been used for women who have hot flashes after chemotherapy or after discontinuing hormone replacement therapy.12,33

Bupropion (Wellbutrin) is useful in lethargic patients (but one needs to monitor for seizures and brain tumors), and in patients who are not eating because of cachexia. The tricyclic antidepressants, especially nortriptyline(Drug information on nortriptyline) and desipramine, can be helpful in patients who have neuropathic pain. Psychostimulants are effective as adjuvant treatments for depression. They decrease fatigue and counteract opioidinduced sedation, particularly in terminally ill patients. In patients with bipolar disorder, mood stabilizers and neuroleptics can be continued during cancer treatment. Levels of lithium(Drug information on lithium) must be carefully monitored, especially if there are complications from chemotherapy, such as nausea, vomiting, and diarrhea. For patients who have anxiety that is not a primary manifestation of depression, benzodiazepines are frequently used in the acute setting, such as when patients need to have MRI scans or other tests, as well as during chemotherapy. Patients often need sleep aids to counter the side effects of corticosteroids, chemotherapy agents, and intrusive thoughts and nightmares.

Bupropion (Wellbutrin) is useful in lethargic patients (but one needs to monitor for seizures and brain tumors), and in patients who are not eating because of cachexia. The tricyclic antidepressants, especially nortriptyline and desipramine, can be helpful in patients who have neuropathic pain. Psychostimulants are effective as adjuvant treatments for depression. They decrease fatigue and counteract opioidinduced sedation, particularly in terminally ill patients. In patients with bipolar disorder, mood stabilizers and neuroleptics can be continued during cancer treatment. Levels of lithium must be carefully monitored, especially if there are complications from chemotherapy, such as nausea, vomiting, and diarrhea. For patients who have anxiety that is not a primary manifestation of depression, benzodiazepines are frequently used in the acute setting, such as when patients need to have MRI scans or other tests, as well as during chemotherapy. Patients often need sleep aids to counter the side effects of corticosteroids, chemotherapy agents, and intrusive thoughts and nightmares.

The advent of newer therapies and a better understanding of the underlying biology of breast cancer make this a more hopeful time in breast cancer research. Patients have more options and choices to make in their treatment. At the same time, the psychological challenges of getting and living with breast cancer remain difficult, and many patients and their families need help in managing psychiatric symptoms and disorders. Our oncology colleagues are grateful to psychiatrists who want to work as part of the multidisciplinary teams who take care of patients with breast cancer during the acute and survivorship phases of this disease.

Dr Riba is director of the psycho-oncology program at the University of Michigan, in Ann Arbor Comprehensive Cancer Center and professor and associate chair for Integrated Medicine and Psychiatric Services in the department of psychiatry at the University of Michigan. She has been a consultant for Eli Lilly, Pfizer, and GlaxoSmithKline.
Pages: 1  2  3  4  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





References
1. Morrell RM, Halyard MY, Schild SE, et al. Breast cancer-related lymphedema. Mayo Clin Proc. 2005;80:1480-1484.
2. American Cancer Society. Estimated new cancer cases for selected cancer sites by state, US, 2005. In: Cancer Fact and Figures. 2005. Available at: www.cancer.org/docroot/MED/content/dowloads/M ED_1_1x_CFF2005_Estimated _New_Cases_ Sites_by_State,asp. Accessed February 23, 2006.
3. American Cancer Society. Estimated new cancer deaths for selected cancer sites by state, US, 2005. In: Cancer Fact and Figures. 2005. Available at: www.cancer.org/docroot/MED/content/dowloads/M ED_1_1x_CFF2005_Estimated _Death_Sites_ by_State,asp. Accessed February 23, 2006.
4. Phillips KA. Current perspectives on BRCA1- and BRCA2-associated breast cancers. Intern Med J. 2001;31:349-356.
5. Peshkin BN, Isaacs C. Evaluation and management of women with BRCA1/2 mutations. Oncology (Williston Park). 2005;19:1451-1468.
6. King MC, Rowell S, Love SM. Inherited breast and ovarian cancer. What are the risks? What are the choices? JAMA. 1993;269:1975-1980.
7. Hall JM, Lee MK, Newman B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 1990;250:1684-1689.
8. Narod SA, Foulkes WD. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer. 2004;4:665-676.
9. Podnos YD, Wagman LD. Surgical management of hepatic breast cancer metastases. Oncology (Williston Park). 2005;19:1583-1588.
10. Jardines L, Callans LS, Torosian MH. Recurrent breast cancer: presentation, diagnosis, and treatment. Semin Oncol. 1993;20:538-547.
11. Esteva FJ, Pusztai L. Optimizing outcomes in HER2-positive breast cancer: the molecular rationale. Oncology (Williston Park). 2005;19(suppl):5-16.
12. Duffy LS, Greenberg DB, Younger J, Ferraro MG. Iatrogenic acute estrogen deficiency and psychiatric syndromes in breast cancer patients. Psychosomatics. 1999;40:304-308.
13. Massie MJ, Greenberg DB. Oncology. In: Levenson JL, ed. American Psychiatric Publishing Textbook of Psychosomatic Medicine. Arlington, Va: American Psychiatric Press; 2005:517-534.
14. Rowland JR, Massie MJ. Psychosocial issues and interventions. In: Harris JR, Lippman ME, Morrow M, et al, eds. Diseases of the Breast. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004:1419-1452.
15. Harlan LC, Abrams J, Warren JL, et al. Adjuvant therapy for breast cancer: practice patterns of community physicians. J Clin Oncol. 2002;20: 1809-1817.
16. Miller SL, Jones LE, Carney CP. Psychiatric sequelae following breast cancer chemotherapy: a pilot study using claims data. Psychosomatics. 2005;46:517-522.
17. Irvine D, Brown B, Crooks D, et al. Psychosocial adjustment in women with breast cancer. Cancer. 1991;67:1097-1117.
18. Maguire P. Psychosocial interventions to reduce affective disorders in cancer patients: research priorities. Psychooncology. 1995;4:113-119.
19. Hann D, Winter K, Jacobsen P. Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res. 1999;46:437-443.
20. Baider L, Kaplan De-Nour A. Psychological distress and intrusive thoughts in cancer patients. J Nerv Ment Dis. 1997;185:346-348.
21. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;57-71.
22. Polsky D, Doshi JA, Marcus S, et al. Long-term risk for depressive symptoms after a medical diagnosis. Arch Intern Med. 2005;165:1260-1266.
23. National Comprehensive Cancer Network. Distress management. Practice guidelines in oncology- v.1.2005. Available at: www.nccn.org. Accessed February 23, 2006.
24. Kerlikowske K, Grady D, Rubin SM, et al. Efficacy of screening mammography. A meta-analysis. JAMA.1995;273:149-154.
25. Brett J, Bankhead C, Henderson B, et al. The psychological impact of mammographic screening. a systematic review. Psychooncology. 2005;14:917-938.
26. Pharoah PD, Day NE, Duffy S, et al. Family history and the risk of breast cancer. a systematic review and meta-analysis. Int J Cancer. 1997;5:800-809.
27. Lloyd S, Watson M, Waites B, et al. Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling. Br J Cancer. 1996; 74:482-487.
28. Zakowski SG, Valdimarsdottir HB, Bovbjerg DH, et al. Predictors of intrusive thoughts and avoidance in women with family histories of breast cancer. Am Behav Med. 1997;19:362-369.
29. Greenstein M, Breitbart W. Cancer and the experience of meaning: a group psychotherapy program for people with cancer. Am J Psychother. 2000; 54:486-500.
30. Chochinov HM. Dignity-conserving care—a new model for palliative care: helping the patient feel valued. JAMA. 2002;287:2253-2260.
31. Goodwin PJ, Leszcz M, Ennis M, et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med. 2001;345:1719-1726.
32. Spiegel D, Bloom JR, Kramer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet. 1989;2:888-891.
33. Stearns V, Isaacs C, Rowland J, et al. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann Oncol. 2000;11:17-22.


 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 


 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Developmental Psychopathology Comes of Age
  • The Moral Struggles of Practicing Psychiatrists
  • Grief and Depression: The Sages Knew the Difference
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Grief and Depression: The Sages Knew the Difference
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Developmental Psychopathology Comes of Age
  • Psychiatry and the Myth of “Medicalization”
  • Experts Discuss Changes, Updates in DSM-5
  • The Paradox of Choice: When More Medications Mean Less Treatment
  • Will Your Clinical Records Support You in Court?
  • Refinements in ECT Techniques
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Grief and Depression: The Sages Knew the Difference
  • Psychiatry and the Myth of “Medicalization”
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • NIMH vs DSM 5: No One Wins, Patients Lose
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • Experts Discuss Changes, Updates in DSM-5
  • New Insight Into the Neurobiology of Depression
  • Tie One On for Patients
  • NIMH vs DSM 5: No One Wins, Patients Lose
  • Psychiatry and the Myth of “Medicalization”
Click here to subscribe to our newsletter
 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry
 
SearchMedica SEARCH RESULT

Find peer-reviewed literature and websites for practicing medical professionals

CME on Display
Evidence on Display
Guidelines on Display
Patient Education on Display
Clinical Trials on Display
Practical Articles on Display
Research and Reviews on Display
All "Display" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy